Nelson Rhodes

2.4k total citations · 1 hit paper
19 papers, 1.6k citations indexed

About

Nelson Rhodes is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Nelson Rhodes has authored 19 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 5 papers in Oncology and 2 papers in Organic Chemistry. Recurrent topics in Nelson Rhodes's work include Cancer-related Molecular Pathways (4 papers), DNA Repair Mechanisms (3 papers) and Reproductive Biology and Fertility (2 papers). Nelson Rhodes is often cited by papers focused on Cancer-related Molecular Pathways (4 papers), DNA Repair Mechanisms (3 papers) and Reproductive Biology and Fertility (2 papers). Nelson Rhodes collaborates with scholars based in United States, United Kingdom and Russia. Nelson Rhodes's co-authors include Beverly Errede, Brian J. Stevenson, G. F. Sprague, Tona M. Gilmer, David W. Rusnak, Krystal J. Alligood, Doris M. Murray, Barry R. Keith, Karen Lackey and Edgar R. Wood and has published in prestigious journals such as Genes & Development, PLoS ONE and Oncogene.

In The Last Decade

Nelson Rhodes

19 papers receiving 1.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The effects of the novel, reversible epidermal growth factor receptor/ErbB-2 tyrosine kinase inhibitor, GW2016, on the growth of human normal and tumor-derived cell lines in vitro and in vivo.

2001 590 citations David W. Rusnak, Karen Lackey et al. PubMed profile →

Peers

Countries citing papers authored by Nelson Rhodes

Since Specialization

Citations

This map shows the geographic impact of Nelson Rhodes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nelson Rhodes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nelson Rhodes more than expected).

Fields of papers citing papers by Nelson Rhodes

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nelson Rhodes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nelson Rhodes. The network helps show where Nelson Rhodes may publish in the future.

Co-authorship network of co-authors of Nelson Rhodes

This figure shows the co-authorship network connecting the top 25 collaborators of Nelson Rhodes. A scholar is included among the top collaborators of Nelson Rhodes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nelson Rhodes. Nelson Rhodes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work	Indexed citations
1	KRAS Genotype Correlates with Proteasome Inhibitor Ixazomib Activity in Preclinical In Vivo Models of Colon and Non-Small Cell Lung Cancer: Potential Role of Tumor Metabolism 2015 ·PLoS ONE ·Nibedita Chattopadhyay, Allison Berger, Erik Koenig, Bret Bannerman, James Garnsey, Hugues Bernard, Paul Hales, (unknown), Yang Yu, Jill Donelan, Kristen G. Jordan, Stephen Tirrell, Bradley Stringer, Cindy Q. Xia, Greg Hather, Katherine Galvin, Mark Manfredi, Nelson Rhodes, (unknown)	14
2	Inflammation and Resolution Are Associated with Upregulation of Fatty Acid β-Oxidation in Zymosan-Induced Peritonitis 2013 ·PLoS ONE ·(unknown), (unknown), Yasuhiro Hayashi, Nelson Rhodes, Lining Guo, Makoto Arita, Takeshi Bamba, Eiichiro Fukusaki	32
3	Metabolic Perturbance in Autism Spectrum Disorders: A Metabolomics Study 2012 ·Journal of Proteome Research ·Xue Ming, T. Peter Stein, Virginia Monsul Barnes, Nelson Rhodes, Lining Guo	193
4	2,3,5-Trisubstituted pyridines as selective AKT inhibitors—Part I: Substitution at 2-position of the core pyridine for ROCK1 selectivity 2009 ·Bioorganic & Medicinal Chemistry Letters ·Hong Lin, Dennis S. Yamashita, Jin Zeng, (unknown), Wenyong Wang, (unknown), Juan I. Luengo, Nelson Rhodes, Victoria B. Knick, Anthony E. Choudhry, Zhihong Lai, Elisabeth A. Minthorn, Susan L. Strum, Edgar R. Wood, P.A. Elkins, N.O. Concha, Dirk A. Heerding	11
5	2,3,5-Trisubstituted pyridines as selective AKT inhibitors. Part II: Improved drug-like properties and kinase selectivity from azaindazoles 2009 ·Bioorganic & Medicinal Chemistry Letters ·Hong Lin, Dennis S. Yamashita, Jin Zeng, (unknown), Sharad K. Verma, Juan I. Luengo, Nelson Rhodes, Shuyun Zhang, Kimberly A. Robell, Anthony E. Choudhry, Zhihong Lai, Rakesh Kumar, Elisabeth A. Minthorn, Kristin K. Brown, Dirk A. Heerding	8
6	A simple method for predicting serum protein binding of compounds from IC 50 shift analysis for in vitro assays 2004 ·Bioorganic & Medicinal Chemistry Letters ·David W. Rusnak, Zhihong Lai, Timothy J. Lansing, Nelson Rhodes, Tona M. Gilmer, Robert A. Copeland	12
7	Chemotherapy-induced alopecia: psychosocial impact and therapeutic approaches 2004 ·Supportive Care in Cancer ·(unknown), (unknown), Mitch Golant, (unknown), Nelson Rhodes, Denise A. Yardley	124
8	The effects of the novel, reversible epidermal growth factor receptor/ErbB-2 tyrosine kinase inhibitor, GW2016, on the growth of human normal and tumor-derived cell lines in vitro and in vivo. breakdown → 2001 ·PubMed ·David W. Rusnak, Karen Lackey, Karen Affleck, Edgar R. Wood, Krystal J. Alligood, Nelson Rhodes, Barry R. Keith, Doris M. Murray, Wilson B. Knight, Robert J. Mullin, Tona M. Gilmer	590
9	Expression and Purification of Active Recombinant ATM Protein from Transiently Transfected Mammalian Cells 2001 ·Protein Expression and Purification ·Nelson Rhodes, Tona M. Gilmer, Timothy J. Lansing	6
10	Monoclonal Antibodies Generated Against Recombinant ATM Support Kinase Activity 2000 ·Hybridoma ·Krystal J. Alligood, Marcos E. Milla, Nelson Rhodes, Byron Ellis, Katherine E. Kilpatrick, Amanda Lee, Tona M. Gilmer, Timothy J. Lansing	7
11	Defective potassium currents in ataxia telangiectasia fibroblasts 1998 ·Genes & Development ·Nelson Rhodes, Theresa D’Souza, (unknown), Yael Ziv, David G. Kirsch, Yosef Shiloh, Michael B. Kastan, Peter H. Reinhart, Tona M. Gilmer	12
12	Serum starved v-mos-transformed cells are unable to appropriately downregulate cyclins and CDKs 1997 ·Oncogene ·Nelson Rhodes, Cynthia L. Innes, Friedrich Propst, Richard S. Paules	10
13	Deregulation of specific E2F complexes by the v-mos oncogene 1997 ·Oncogene ·Cynthia A. Afshari, Nelson Rhodes, Richard S. Paules, Maria Mudryj	7
14	Molecular mechanisms of environmental carcinogenesis. 1995 ·Environmental Health Perspectives ·Nelson Rhodes, Richard S. Paules, (unknown)	2
15	Defective G2 checkpoint function in cells from individuals with familial cancer syndromes. 1995 ·PubMed ·Richard S. Paules, Eleni N. Levedakou, (unknown), Cynthia L. Innes, Nelson Rhodes, Thea D. Tlsty, Denise A. Galloway, L A Donehower, Michael A. Tainsky, William K. Kaufmann	126
16	v-mos-Transformed Cells Fail to Enter Quiescence but Growth Arrest in G1 Following Serum Withdrawal 1994 ·Experimental Cell Research ·Nelson Rhodes, Ray Hicks, (unknown), Cynthia L. Innes, Richard S. Paules, Friedrich Propst	4
17	Constitutive mutants of the protein kinase STE11 activate the yeast pheromone response pathway in the absence of the G protein. 1992 ·Genes & Development ·Brian J. Stevenson, Nelson Rhodes, Beverly Errede, G. F. Sprague	261
18	A yeast-Escherichia coli shuttle vector containing the M13 origin of replication 1990 ·Plasmid ·Nelson Rhodes, Beverly Errede	17
19	STE11 is a protein kinase required for cell-type-specific transcription and signal transduction in yeast. 1990 ·Genes & Development ·Nelson Rhodes, Laurie B. Connell, Beverly Errede	157

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact